Fidelity Investments’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,062
| Closed | -$15.6K | – | 5638 |
|
|
2024
Q4 | $15.6K | Sell |
30,062
-86,482
| -74% | -$45K | ﹤0.01% | 4279 |
|
|
2024
Q3 | $378K | Buy |
116,544
+26,185
| +29% | +$84.8K | ﹤0.01% | 2967 |
|
|
2024
Q2 | $271K | Buy |
90,359
+6,512
| +8% | +$19.5K | ﹤0.01% | 2931 |
|
|
2024
Q1 | $390K | Sell |
83,847
-301
| -0.4% | -$1.4K | ﹤0.01% | 2805 |
|
|
2023
Q4 | $348K | Sell |
84,148
-132
| -0.2% | -$546 | ﹤0.01% | 2781 |
|
|
2023
Q3 | $253K | Sell |
84,280
-269
| -0.3% | -$807 | ﹤0.01% | 2814 |
|
|
2023
Q2 | $208K | Sell |
84,549
-4,929
| -6% | -$12.1K | ﹤0.01% | 2940 |
|
|
2023
Q1 | $202K | Buy |
89,478
+5,723
| +7% | +$12.9K | ﹤0.01% | 2974 |
|
|
2022
Q4 | $292K | Buy |
83,755
+83,151
| +13,767% | +$290K | ﹤0.01% | 2893 |
|
|
2022
Q3 | $22K | Buy |
604
+386
| +177% | +$14.1K | ﹤0.01% | 3811 |
|
|
2022
Q2 | $4K | Sell |
218
-15
| -6% | -$275 | ﹤0.01% | 4399 |
|
|
2022
Q1 | $6K | Buy |
233
+213
| +1,065% | +$5.49K | ﹤0.01% | 4396 |
|
|
2021
Q4 | $0 | Buy |
+20
| New | – | ﹤0.01% | 4848 |
|